Requirement of Bmpr1a for Müllerian duct regression during male sexual development

Nature Genetics

Volumn 32, Issue 3, 2002, Pages 408-410

  Jamin, Soazik P ^a   Arango, Nelson A ^a   Mishina, Yuji ^a   Hanks, Mark C ^b   Behringer, Richard R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Health Care Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR; MUELLERIAN INHIBITING FACTOR; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL TISSUE; ARTICLE; BINDING KINETICS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE DISRUPTION; GENE EXPRESSION; GENE MUTATION; IN VIVO STUDY; MALE; MESENCHYME CELL; MOLECULAR EVOLUTION; MOUSE; MUELLERIAN DUCT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENTIATION; SEXUAL DEVELOPMENT; SIGNAL TRANSDUCTION;

ACTIVIN RECEPTORS, TYPE I; ALLELES; ANIMALS; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; EXONS; IN SITU HYBRIDIZATION; LIGANDS; MALE; MICE; MICE, TRANSGENIC; MODELS, GENETIC; MULLERIAN DUCTS; MUTATION; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, GROWTH FACTOR; RECOMBINATION, GENETIC; SEX DIFFERENTIATION; TESTIS; TIME FACTORS;

AMNIOTA; ANIMALIA; MAMMALIA;

EID: 0036842115     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1003     Document Type: Article

References (30)

1. Josso, N. et al. Anti-Müllerian hormone: The Jost factor. Recent Prog. Horm. Res. 48, 1-59 (1993).
2. Jost, A. Problems of fetal endocrinology: The gonadal and bypophyseal hormones. Recent Prog. Horm. Res. 8, 379-418 (1953).
3. Baarends, W.M. et al. A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the Müllerian duct. Development 120, 189-197 (1994).
4. di Clemente, N. et al. Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone. Mol. Endocrinol. 8, 1006-1020 (1994).
5. Teixeira, J. et al. Developmental expression of a candidate Müllerian inhibiting substance type II receptor, Endocrinology 137, 160-165 (1996).
6. Roberts, L.M., Hirokawa, Y., Nachtigal, M.W. & Ingraham, H.A. Paracrine-mediated apoptosis in reproductive tract development. Dev. Biol. 208, 110-122 (1999).
7. Allard, S. et al. Molecular mechanisms of hormone-mediated Müllerian duct regression: Involvement of β-catenin. Development 127, 3349-3360 (2000).
8. Behringer, R.R., Finegold, M.J. & Cate, R.L. Müllerian-inhibiting substance function during mammalian sexual development. Cell 79, 415-425 (1994).
9. Mishina, Y. et al. Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev. 10, 2577-2587 (1996).
10. Belville, C., Josso, N. & Picard, J.Y. Persistence of Müllerian derivatives in males. Am. J. Med. Genet. 89, 218-223 (1999).
11. Massagué, J., Blain, S.W. & Lo, R.S. TGF-β signaling in growth control, cancer, and heritable disorders. Cell 103, 295-309 (2000).
12. Gouédard, L. et al. Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Müllerian hormone and its type II receptor. J. Biol. Chem. 275, 27973-27978 (2000).
13. Clarke, T.R. et al. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression. Mol. Endocrinol. 15, 946-959 (2001).
14. Visser, J.A. et al. The serine/threonine transmembrane receptor ALK2 mediates Müllerian inhibiting substance signaling. Mol. Endocrinol. 15, 936-945 (2001).
15. Mishina, Y., Suzuki, A., Ueno, N. & Behringer, R.R. Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev. 9, 3027-3037 (1995).
16. Gu, Z. et al. The type I activin receptor ActR1B is required for egg cylinder organization and gastrulation in the mouse. Genes Dev. 12, 844-857 (1998).
17. Gu, Z. et al. The type I serine/threonine kinase receptor ActR1A (Alk2) is required for gastrulation of the mouse embryo. Development 126, 2551-2561 (1999).
18. Mishina, Y., Crombie, R., Bradley, A. & Behringer, R.R. Multiple roles for activin-like kinase-2 signaling during mouse embryogenesis. Dev. Biol. 213, 314-326 (1999).
19. Oh, S.P. et al. Activin receptor-like kinase 1 modulates transforming growth factor-β 1 signaling in the regulation of angiogenesis. Proc. Natl Acad. Sci. USA 97, 2626-2631 (2000).
20. Yi, S.E., Daluiski, A., Pederson, R., Rosen, V. & Lyons, K.M. The type I BMP receptor BMPR1B is required for chondrogenesis in the mouse limb. Development 127, 621-630 (2000).
21. Yi, S.E. et al. The type I BMP receptor Bmpr1B is essential for female reproductive function. Proc. Natl Acad. Sci. USA 98, 7994-7999 (2001).
22. Durlinger, A.L. et al. Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary. Endocrinology 140, 5789-5796 (1999).
23. Nagy, A. Cre recombinase: The universal reagent for genome tailoring. Genesis 26, 99-109 (2000).
24. Arango, N.A., Lovell-Badge, R. & Behringer, R.R. Targeted mutagenesis of the endogenous mouse Mis gene promoter: In vivo definition of genetic pathways of vertebrate sexual development. Cell 99, 409-419 (1999).
25. Soriano, P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21, 70-71 (1999).
26. Mishina, Y., Hanks, M.C., Miura, S., Tallquist, M.D. & Behringer, R.R. Generation of Bmpr/Alk3 conditional knockout mice. Genesis 32, 69-72 (2002).
27. Ahn, K., Mishina, Y., Hanks, M.C., Behringer, R.R. & Crenshaw, E.B. 3rd. BMPR-1A signaling is required for the formation of the apical ectodermal ridge and dorsal-ventral patterning of the limb. Development 128, 4449-4461 (2001).
28. Gaussin, V. et al. Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3. Proc. Natl. Acad. Sci. USA 99, 2878-2883 (2002).
29. Newfeld, S.J., Wisotzkey, R.G. & Kumar, S. Molecular evolution of a developmental pathway: Phylogenetic analyses of transforming growth factor-b family ligands, receptors and Smad signal transducers. Genetics 152, 783-795 (1999).
30. Albrecht, U. et al. Platelet-activating factor acetylhydrolase expression and activity suggest a link between neuronal migration and platelet-activating factor. Dev. Biol. 180, 579-593 (1996).